Group One Trading, L.P. Cue Biopharma, Inc. Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$2.23 - $4.69 $11,769 - $24,753	5,278 New	5,278 $12,000
Q1 2023 May 12, 2023	BUY	$2.41 - $3.74 $3,802 - $5,901	1,578 New	1,578 $5,000
Q2 2022 Aug 11, 2022	BUY	$2.49 - $5.92 $24,446 - $58,122	9,818 Added 206.26%	14,578 $36,000
Q1 2022 May 12, 2022	BUY	$4.41 - $12.28 $20,991 - $58,452	4,760 New	4,760 $23,000
Q4 2021 Feb 11, 2022	SELL	$10.86 - $17.85 $3,377 - $5,551	-311 Closed	0 $0

Q3 2021 Nov 12, 2021	SELL	$10.06 - $15.3 $14,053 - $21,374	-1,397 Reduced 81.79%	311 $5,000
Q2 2021 Aug 10, 2021	BUY	$10.9 - $14.53 $18,617 - $24,817	1,708 New	1,708 $20,000

16.3M

12.9K

39.1K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.